NCT07872059Not yet recruiting
Prevalence and Clinical Significance of Hematological Abnormalities in Patients With Clinically Diagnosed Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Case-Control Study
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
this study aims to investigate the prevalence of hematological abnormalities among patients with clinically diagnosed MASLD, evaluate their clinical correlates, and examine their association with non-invasive fibrosis scores. The findings may improve risk stratification and facilitate early identification of patients who require closer monitoring or further hepatological assessment.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 4 Sept 2026
- Start date
- 1 Nov 2026
- Primary completion date
- 1 May 2027
- Lead sponsor
- Assiut University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07872059
What you commit to
- Study type: Observational
- Planned participants: 120
- From 1 Nov 2026 to the primary completion date, 1 May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Alcoholic liver disease.
- Viral hepatitis.
- Autoimmune liver diseases.
- Other chronic liver diseases or secondary causes of hepatic steatosis.
Lab values
- Patients with unavailable essential laboratory or clinical data.
Age
- Age below 18 years.
Who the study is looking for
- Adults aged ≥18 years.
- Patients with a clinical diagnosis of MASLD based on fibroscan records.
- Availability of complete blood count (CBC) data.
- Availability of relevant demographic and clinical information.
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.